Has More Ranked Pediatric Programs Than Any Other South Florida Hospital 
 
June 15 2021 – Five Nicklaus Children’s Hospital specialty programs are again identified among the best in the nation, according to U.S.News & World Report’s 2021-22 “Best Children’s Hospitals” rankings, posted online today. Nicklaus Children’s continues to be the region’s pediatric specialty care leader, with more ranked pediatric programs than any other hospital in South Florida. In addition, this year’s rankings identify Nicklaus Children’s as among the best pediatric hospitals in Florida, as well as in the southeastern region of the U.S. 
 
Nicklaus Children’s 2021-22 rankings are as follows:
–Cardiology & Heart Surgery, #46 (highest ranked program in South Florida) 
–Diabetes & Endocrinology, #49
–Neurology & Neurosurgery, #24 (only ranked program in South Florida)
–Orthopedics, #40
–Pulmonology, #36 (only ranked program in South Florida)
 
“Nicklaus Children’s is honored to again be recognized for the excellence of our pediatric specialty programs,” said Matthew A. Love, president and CEO of Nicklaus Children’s Health System. “Our longstanding leadership speaks to the dedication of our physicians, nurses and staff and their shared commitment to care excellence, and supporting the medical needs of the children of our region and beyond.” 
 
A total of 118 hospitals participated in the 2021-2022 U.S. News & World Report survey. The methodology is based on clinical outcomes such as patient survival, infection rates and complications; the level and quality of hospital resources directly related to patient care such as staffing, technology and special services; delivery of healthcare programs that prevent infections and adherence to best practices; and expert opinion among pediatric specialists and subspecialists. The survey is updated every year, designed to account for new treatments and evidence-based best practices, informed by leading experts in the field.
                                                                
About Nicklaus Children’s Hospital 
Founded in 1950 by Variety Clubs International, Nicklaus Children’s Hospital is South Florida’s only licensed specialty hospital exclusively for children, with nearly 800 attending physicians and more than 475 pediatric subspecialists. The 309-bed hospital, known as Miami Children’s Hospital from 1983 through 2014, is renowned for excellence in all aspects of pediatric medicine with several specialty programs routinely ranked among the best in the nation by U.S. News & World Report since 2008. The hospital is also home to the largest pediatric teaching program in the southeastern United States and has been designated an American Nurses Credentialing Center (ANCC) Magnet facility, the nursing profession’s most prestigious institutional honor. For more information, please visit www.nicklauschildrens.org
 


 
Guidelines for health care organizations provide direction on effective anti-discrimination policies
 
June 15 2021 – The nation’s physicians and medical students today continued to acknowledge the realities of structural racism in medicine by adding to policy that informs the American Medical Association’s ambitious work to dismantle racist policies and practices across all of health care.
 
Members of the AMA’s House of Delegates representing their peers from all corners of medicine voted to adopt guidelines addressing systemic racism in medicine, including discrimination, bias and abuse, including expressions of prejudice known as microaggressions. The AMA will recommend that health care organizations and systems use the new guidelines to establish institutional policies that promote positive cultural change and ensure a safe, discrimination-free work environment. 
 
“Systemic racism in medicine is the most serious barrier to the advancement of health equity and appropriate medical care,” said AMA Board Member Willarda V. Edwards, M.D., M.B.A. “Today’s actions by the House of Delegates will inform the AMA’s active work to proactively identify, prevent, and eliminate racism and will help the AMA guide health care organizations in efforts to adopt workplace policies that promote positive cultural transformation and address the root cause of racial health inequities.”
 
According to the newly adopted guidelines, an effective workplace policy to address systemic racism in a health care setting should:
 
Clearly define discrimination, systemic racism, explicit and implicit bias and microaggressions in the healthcare setting. 
Ensure the policy is prominently displayed and easily accessible.
Describe the management’s commitment to providing a safe and healthy environment that actively seeks to prevent and address systemic racism, explicit and implicit bias and microaggressions.
Establish training requirements for systemic racism, explicit and implicit bias, and microaggressions for all members of the healthcare system.
Prioritize safety in both reporting and corrective actions related to discrimination, systemic racism, explicit and implicit bias and microaggressions.
Create anti-discrimination policies that: 
Specify to whom the policy applies (i.e., medical staff, students, trainees, administration, patients, employees, contractors, vendors, etc.).
Define expected and prohibited behavior.
Outline steps for individuals to take when they feel they have experienced discrimination, including racism, explicit and implicit bias and microaggressions.
Ensure privacy and confidentiality to the reporter.
Provide a confidential method for documenting and reporting incidents.
Outline policies and procedures for investigating and addressing complaints and determining necessary interventions or action.
 
These policies should include:
Taking every complaint seriously.
Acting upon every complaint immediately.
Developing appropriate resources to resolve complaints.
Creating a procedure to ensure a healthy work environment is maintained for complainants and prohibit and penalize retaliation for reporting.
Communicating decisions and actions taken by the organization following a complaint to all affected parties.
oDocument training requirements to all the members of the healthcare system and establish clear expectations about the training objectives.
 
The guidelines also suggest tactics that can help medical staff leaders establish work environments within their institutions that are safe and discrimination-free.
 
In the past year, the House of Delegates has adopted several policies that explicitly acknowledge racism’s role in perpetuating health inequities and inciting harm against historically marginalized communities. These AMA policies include acknowledging racism as a public health threat, removing race as a proxy for biology and eliminating racial essentialism in medicine.
 
Through research, collaborations, advocacy, and leadership, the AMA believes in supporting system-level solutions and identifying and addressing root causes of health inequities while elevating their importance to patients, communities, and stakeholders. 
 


Company to sponsor Tampa, Greater Orlando and Broward County events
 
June 14, 2021 – During the COVID-19 pandemic, technology company iN2L provided the state of Florida with tablets to help connect socially-isolated seniors with their loved ones through Project VITAL (Virtual Inclusive Technology for All). Now, the company is building on that support by joining the Alzheimer’s Association as a 2021 Walk to End Alzheimer’s sponsor in Tampa, Greater Orlando and Broward County. 
 
“IN2L is honored to sponsor the Alzheimer’s Association Walk to End Alzheimer’s,” said Allison Hart, vice president of marketing for iN2L. “The Alzheimer’s Association continues to provide valuable support services to individuals living with Alzheimer’s and their caregivers while also supporting critically-needed research. As a company dedicated to improving the lives of older adults and working with organizations to provide direct care and support for hundreds of thousands of older adults daily, we are aware of the dramatic impact Alzheimer’s has on individuals, families and communities and are committed to ongoing support of this important cause.”
Angela McAuley, regional leader for the Florida chapters of the Alzheimer’s Association, said: “Over the past year, the iN2L team has really stepped up in support of Florida’s older adult population. Now, with this sponsorship, they are providing hope to the more than 580,000 Floridians living with Alzheimer’s and other dementia, and we couldn’t be more grateful to have them supporting us in our mission.”
 
According to the Alzheimer’s Association, more than 6 million Americans are living with Alzheimer’s disease – a leading cause of death in the United States. Additionally, more than 11 million family members and friends provide care to people living with Alzheimer’s and other dementias. 
 
The Alzheimer’s Association Walk to End Alzheimer’s is the world’s largest event to raise awareness and funds for Alzheimer’s care, support and research. Although last year’s event was mainly virtual due to COVID-19, the Alzheimer’s Association is moving forward with plans to host the event in person this fall. 
 
“As we continue monitoring the pandemic, the health and safety of Walk to End Alzheimer’s participants, volunteers and staff remain our top priorities,” McAuley said. “While we intend to gather in person, we will also offer options to participate online and in communities across the country.”
 
The Greater Orlando, Broward County and Tampa Walks to End Alzheimer’s are scheduled for Oct. 23, Nov. 6 and Nov. 13, respectively. For more information and to receive the latest updates on this year’s Alzheimer’s Association Walk to End Alzheimer’s, visit alz.org/walk. 
 
Alzheimer’s Association Walk to End Alzheimer’s® 
The Alzheimer’s Association Walk to End Alzheimer’s is the world’s largest event to raise awareness and funds for Alzheimer’s care, support and research. Since 1989, the Alzheimer’s Association mobilized millions of Americans in the Alzheimer’s Association Memory Walk®; now the Alzheimer’s Association is continuing to lead the way with Walk to End Alzheimer’s. Together, we can end Alzheimer’s. 
 
Alzheimer’s Association®
The Alzheimer’s Association is a worldwide voluntary health organization dedicated to  Alzheimer’s care, support and research. Its mission is to lead the way to end Alzheimer’s and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Visit alz.org or call 800.272.3900. 
 


Combined Company Known as “CareMax, Inc.” Scheduled to Commence Trading on NASDAQ Global Select Market Under Ticker Symbol “CMAX”
 
June 14, 2021 – Deerfield Healthcare Technology Acquisitions Corp. ("DFHT") (NASDAQ: DFHT), a special purpose acquisition company sponsored by an affiliate of Deerfield Management Company, L.P. (“Deerfield”), and Richard Barasch, a veteran healthcare public company executive and investor, announced today that it has closed its business combination with CareMax Medical Group, L.L.C. and IMC Medical Group Holdings LLC (“IMC”), creating a technology-enabled care platform providing value-based care and chronic disease management to seniors. As previously announced, the transaction was approved at a special meeting of DFHT’s stockholders held on June 4, 2021.
 
The combined company, which has been renamed CareMax, Inc. (“CareMax”), expects that its Class A common stock and public warrants will commence trading on the Nasdaq Global Select Market under the new trading symbols “CMAX” and “CMAXW”, respectively, starting on Wednesday, June 9, 2021.
 
Immediately following closing, CareMax will own and operate 26 multi-specialty medical centers throughout South Florida. CareMax has recently signed definitive agreements for 4 acquisitions, which it believes will be accretive, covering approximately 3,600 full and partial risk Medicare lives. Two of these acquisitions recently closed and the remaining two acquisitions are subject to customary closing conditions and are expected to close during the second quarter of this year. CareMax will continue to be led by its seasoned team of industry professionals, including Chief Executive Officer, Carlos de Solo; Executive Vice President, William Lamoreaux; Chief Financial Officer, Kevin Wirges; Chief Medical Officer, Niberto Moreno MD; Chief Operating Officer, Albert de Solo; and Chief Strategy Officer, Ben Quirk.
 
“On behalf of the team at DFHT and Deerfield, I am very pleased to announce the closing of this business combination,” said Richard Barasch, who will serve as Executive Chairman of CareMax. “The CareMax team has created a foundational senior-focused healthcare delivery platform that combines high-touch patient care, vertical care coordination and delivery, and a highly scalable technology backbone. We believe this differentiated model facilitates members receiving the right care at the right time in the most efficient setting. CareMax has become the platform of choice for payors, providers, and patients. Working collaboratively, we believe that the success that CareMax has experienced regionally can be replicated to other markets across the country.”
 
“We look forward to this next, exciting phase of our growth as a public company,” said Mr. de Solo. “We created the CareMax platform to address a fundamental flaw in our nation’s healthcare system: the current fee-for-service business model is failing the elderly and the taxpayer. By interceding early on the primary care level, we have demonstrated that we can improve patient outcomes and lower senior healthcare spending through the prevention and management of chronic disease. We expect to grow organically and via acquisition, while remaining focused both on providing the highest level of patient care and delivering long-term shareholder value. We believe our pipeline for acquisitions remains robust as providers seek to align themselves with our model of value-based care.”
 
CareMax focuses on providing access to high quality care in underserved communities, with approximately 65 percent of its Medicare Advantage patients being dual-eligible and low-income subsidy eligible as of December 31, 2020. CareMax has contractual relationships with some of the largest and most established payors in the industry.
 
CareMax’s comprehensive, high-touch approach to health care delivery is powered by its CareOptimize technology platform, a proprietary end-to-end technology solution that aggregates and analyzes data using artificial intelligence and machine learning to support more informed care delivery decisions and to focus care decisions on preventative chronic disease management and the social determinants of health. The CareOptimize technology platform also provides CareMax with a national reach beyond its South Florida presence. As of December 31, 2020, the CareOptimize platform was used by approximately 20,000 providers in more than 30 states, including IMC, which CareMax believes will facilitate the integration and operation of the combined company while also providing a pipeline for potential future acquisitions.
 
The business combination was funded by approximately $144 million in cash held in the DFHT trust account, over $400 million through a private placement in public equity including Deerfield, Fidelity Management & Research, LLC, Eminence Capital, LP, funds and accounts managed by BlackRock, and Maverick Capital, and $125 million in debt financing through a $185 million senior secured credit facility, with RBC Capital Markets, LLC and Truist Securities, Inc. acting as joint leading arrangers and joint bookrunners for the facility. Total cash consideration payable to the equityholders of CareMax Medical Group, L.L.C. and IMC was approximately $229.4 million and $85.2 million, respectively, net of debt and subject to ordinary adjustments, representing approximately 68% and 45%, respectfully of the value of each business.
 
Deutsche Bank Securities Inc. and UBS Investment Bank acted as financial advisors and capital markets advisors to DFHT, Morgan Stanley & Co. LLC acted as financial advisor to CareMax Medical Group, L.L.C. and Piper Sandler acted as financial advisor to IMC. DLA Piper LLP (US) acted as legal advisor to CareMax Medical Group, L.L.C., McDermott Will & Emery LLP acted as legal advisor to IMC, White & Case LLP and Polsinelli PC acted as legal advisors to DFHT and Katten Muchin Rosenman LLP acted as legal advisor to Deerfield.
 
CareMax’s Board of Directors is comprised of healthcare industry veterans, with specialties in managed care, process improvement, audit, investing, government, and research.
 
“We are pleased to welcome these individuals as members of CareMax’s Board of Directors,” said Mr. de Solo. “Their knowledge, insight and experience will be invaluable as we begin this period of transformation and continue our growth and evolution as a provider of senior-focused value-based care and chronic disease management in Florida and across the United States.”
 
The Board of Directors is comprised of the following individuals:
 
Richard Barasch
 
Richard Barasch has served as DFHT’s Chairman since May 2020 and will serve as Executive Chairman following the closing of the business combination. Mr. Barasch was formerly Chairman and CEO of Universal American Corp., a publicly traded health insurance and services company focused on the senior market and government programs, from 1995 until Universal American’s acquisition by WellCare Health Plans in May 2017. He also serves as Chairman of AdaptHealth Corp. (Nasdaq: AHCO), which went public in 2019 via a business combination with DFB Healthcare Acquisitions Corp, and is a founding partner of RAB Ventures, formed to invest in growth healthcare companies. Mr. Barasch serves on the Board of Trustees of the Maimonides Medical Center in Brooklyn, New York. Mr. Barasch graduated from Swarthmore College and Columbia University Law School.
 
Carlos A. de Solo
 
Carlos A. de Solo is the President, CEO and a co-founder of CareMax. He has served in those capacities since May 2011. Before co-founding CareMax, he served as COO and partner of Solera Health Systems, LLC, a startup managed healthcare company. Mr. de Solo also serves as a board member of the Coral Gables Hospital. Mr. de Solo received a B.B.A. in Accounting and Finance from Florida International University.
 
Dr. Jennifer Carter
 
Dr. Jennifer Carter is a board-certified internist and healthcare entrepreneur with over 20 years of experience evaluating existing and emerging markets, new medical technologies and early-stage companies in the healthcare field. She is currently Managing Director of JLC Precision Health Strategies, LLC, a strategy and innovation consulting company that advises data-driven healthcare and life science companies on their commercial and financing strategy and the development of novel products and services. In 2018, Dr. Carter founded TrialzOWN, Inc. and was CEO until its prelaunch acquisition by Integral Health (now Valo Health) in 2019. Dr. Carter has a B.S. in Molecular Biophysics and Biochemistry from Yale University, an M.D. from Harvard Medical School, an M.P.H. from Harvard School of Public Health and an M.B.A. from the Sloan School at Massachusetts Institute of Technology.
 
Jose R. Rodriguez
 
Before he retired on March 31, 2021, Jose R. Rodriguez was a senior audit partner at KPMG LLP (KPMG). During his career at KPMG, he held various leadership positions, including as lead director of the board of directors, COO of KPMG International’s global audit practice, office managing partner, leader of its Audit Committee Institute (ACI), east region professional practice partner and, most recently, ombudsman. Mr. Rodriguez brings to the board in-depth knowledge and understanding of generally accepted accounting principles, experience in auditing and SEC reporting, mergers and acquisitions, familiarity with the responsibilities and functions of audit committees and expertise in corporate governance. Mr. Rodriguez received a B.B.A. with a major in accounting from the University of Miami.
 
Hon. David J. Shulkin, M.D.
 
Hon. David J. Shulkin, M.D., a board-certified internist with executive healthcare management experience, has served as an independent director of DFHT since July 2020. Dr. Shulkin served as the ninth United States Secretary of Veterans Affairs from February 2017 to April 2018 and the Under Secretary of Veterans Affairs for Health from July 2015 to February 2017. Before arriving to such appointments, Dr. Shulkin was CEO of various leading hospitals and health systems, including Beth Israel in New York City and Morristown Medical Center in Northern New Jersey. He has held numerous physician leadership roles and academic positions, and founded DoctorQuality, one of the first consumer-orientated sources of information for quality and safety in healthcare. Dr. Shulkin received his M.D. from the Medical College of Pennsylvania, did his internship at Yale University School of Medicine, and his Residency and Fellowship in General Medicine at the University of Pittsburgh Presbyterian Medical Center. He received advanced training in outcomes research and economics as a Robert Wood Johnson Foundation Clinical Scholar at the University of Pennsylvania.
 
Randy Simpson
 
Randy Simpson, who was Partner and Head of the Healthcare Group at Glenview Capital Management, brings significant investment experience to the board. He joined Glenview Capital Management in September 2005 and was named Partner in April 2011. As a senior member of Glenview Capital Management’s investment team, Mr. Simpson managed Glenview Capital Management’s healthcare investments through 2019. Before joining Glenview Capital Management, he was an equity research analyst at Goldman Sachs. Mr. Simpson received his M.B.A. in Finance and Accounting from the University of Chicago, his J.D. from Georgetown University Law Center and his B.A. in Quantitative Economics and Decision Sciences from the University of California, San Diego.
 
About CareMax
 
CareMax is a technology-enabled care platform providing value-based care and chronic disease management to seniors. Collectively, CareMax operates 26 wholly-owned medical centers that offer a comprehensive suite of healthcare and social services, and a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians across the United States. Learn more at www.caremax.com.


June 14, 2021 – In support of children and families with special healthcare needs, Children’s Diagnostic & Treatment Center (CDTC) will host the 15th Annual Ribbons for the Children on Thursday, September 23 from 6 to 9 p.m. at the Galleria in Fort Lauderdale. 
 
Guests will enjoy a fabulous selection of wines and passed hors d’oeuvres from Galleria’s premier restaurants, such as Cooper’s Hawk, as well as other local restaurants and have the opportunity to bid on original work created and donated by talented local artists. This year’s art exhibition will feature both a silent and online auction. 
 
“We are proud that 100% of proceeds from the art auction directly support CDTC’s programs and services for the children and families in our community,” said Chuck Williams, event founder and co-chair. “We are incredibly grateful to all the local artists who continue to come back each year and for the new artists who generously donate their time and talent to support the mission of CDTC.”   
 
Ribbons for the Children has evolved and expanded from a predominately HIV-centric awareness event to include a focus on the numerous severe health conditions CDTC patients face every day.
 
“The children and families at CDTC face incredible health obstacles. Ribbons for the Children is a special evening which raises much-needed funds for them and generates awareness for CDTC,” said Maria Pierson, event co-chair and CEO of Pierson Grant Public Relations. “We are thrilled with our new location at Galleria and the new experiences we’ll offer our guests. This is a tremendous opportunity for them to take home beautiful, affordable artwork while at the same time supporting the most vulnerable in our community who receive outstanding and critical medical, dental and care coordination services at CDTC.” 
 
Tickets are available for presale purchase of $75 before September 1. Tickets are $100 after September 1 at childrensdiagnostic.com/ribbons-for-the-children/
 
Contact Jessica Vones at 954.728.1040 or jvones@browardhealth.org for sponsorship inquiries.
 
About CDTC                                                                                                                                   
Children’s Diagnostic & Treatment Center (CDTC) is a not-for-profit that serves more than 12,000 clients with special healthcare needs in Broward County annually. As a facility of Broward Health, CDTC’s mission is to promote the optimal health and well-being of children with special healthcare needs by providing comprehensive prevention, intervention, and treatment services. CDTC has been awarded recognition by the National Committee for Quality Assurance (NCQA) Patient-Centered Medical Home (PCMH) Program for offering a unique system of care for infants, children, youth and women with chronic illnesses, disabilities, and developmental delays